Pharmacopeia, CV Therapeutics Enter Drug Discovery Collaboration

Pharmacopeia Drug Discovery has entered into a drug discovery and development collaboration with CV Therapeutics.

The partners will work toward the development of novel therapeutics. Under the terms of the agreement, Pharmacopeia is employing its comprehensive, integrated drug discovery platform and discovery expertise that has, to date, resulted in four programs advancing into human clinical trials with its partners. CV Therapeutics will be responsible for development and marketing of collaboration products, and will bring its substantial pharmacology and clinical expertise and experience to the collaboration.

Pharmacopeia will receive research funding in addition to clinical milestones and royalties if and when the collaboration products advance through clinical development and onto the market.